PharmaEssentia
MA - BurlingtonBiotechnology
Focus: PharmaEssentia is a Massachusetts-based biotech company focused on biologics development in hematology, oncology, infectious diseases, and immunology, with a marketed product generating $40M in Part D spending.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Open Jobs
0
About PharmaEssentia
AI assessmentNot HiringNo open roles listed right now. Follow PharmaEssentia to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from PharmaEssentia's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
10 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$40MGrowing
Peak
Lead marketed product with dual FDA approvals (2026) and recent pen formulation launch; sole revenue driver sustaining company operations.
Products & Portfolio (1)
Help build intelligence for PharmaEssentia
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.